Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

BTTX Better Therapeutics Inc

0,0446

0,00 (0,00%)

25 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Better Therapeutics Charts.

Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Better Therapeutics Charts.

News Better Therapeutics Inc

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
Donnerstag 14 März 2024 (3 Monate vor) • Business Wire

Form 8-K - Current report
Montag 11 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers
Dienstag 5 März 2024 (4 Monate vor) • Business Wire

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Montag 4 März 2024 (4 Monate vor) • Business Wire

Form 8-K - Current report
Montag 4 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Form RW - Registration Withdrawal Request
Freitag 1 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
Dienstag 20 Februar 2024 (4 Monate vor) • Business Wire

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Montag 12 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment
Dienstag 6 Februar 2024 (5 Monate vor) • Business Wire

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dienstag 6 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Donnerstag 25 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Dienstag 23 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Better Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen